Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Scrip Team
Come and celebrate your vital contribution to improving human health worldwide – the 2019 Scrip Awards is now open for entries.
Exiting Gilead biology leader lands CSO post at blood cancer company Amphivena Therapeutics. Sanofi moves its Brazil general manager to head China Emerging Markets Business Unit and Mitsubishi Tanabe Pharma America promotes area director to VP, ops and strategy.
Executives On The Move: Bio/Med Changes Made From Lilly And Amgen, And A Step Up R&D Ladder At Daiichi Sankyo
Eli Lilly & Co’s Biology VP takes on SVP, Discovery role at gene regulatory mechanism firm Fulcrum Therapeutics, and Amgen Med Affairs exec becomes CMO at Matinas BioPharma Holdings. At Daiichi Sankyo, R&D leader steps up to Global Head, R&D position.
Executives On The Move: CEOs Welcomed At Cadent Therapeutics And Enzyvant Sciences, And Top Development Spot Filled At Bicycle Therapeutics
A new CEO for movement and cognitive disorder company Cadent Therapeutics, and Alexion SVP departs for CEO position at rare disease therapy firm Enzyvant Sciences. Plus transatlantic biotech Bicycle Therapeutics appoints a CBO, while Simon Moroney announces his departure from MorphoSys.
Executives On The Move: New Responsibilities For Sanofi CMO, A Strategic Promotion At Alexion And A C-Level Resignation At Medivir
To integrate digital and medical, Sanofi’s CMO Ameet Nathwani is now also Chief Digital Officer. Alexion promotes SVP to Chief Strategy and Business Development Officer, and the CFO resigns from Swedish oncology biotech Medivir.
C-suite moves at cancer biotech Geron Corp, EMD Serono Inc and Kiadis Pharma, while German biotech MorphoSys AG names David Trexler as its new president.